Kah-Ling is a research fellow at the Centre for Health Economics, Monash Business School.  She works with the health technology assessment team to evaluate the comparative clinical- and cost-effectiveness of medical technologies for funding on the national insurance schemes.  Her work directly inform recommendations by the Pharmaceutical Benefits Advisory Committee (PBAC) in Australia and the Agency for Care and Effectiveness (ACE) in Singapore.

Her other research interests include economic evaluation alongside clinical trials and analyses of health care funding and policy decisions.